Potiga FDA Approval History
FDA Approved: Yes (Discontinued) (First approved June 10, 2011)
Brand name: Potiga
Generic name: ezogabine
Dosage form: Tablets
Treatment for: Seizures
Marketing Status: Discontinued
Potiga (ezogabine) is a potassium channel opener indicated for the adjunctive treatment of adults with partial-onset seizures.
Development timeline for Potiga
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.